デフォルト表紙
市場調査レポート
商品コード
1470966

点滴液市場:タイプ別、組成液別、エンドユーザー別-2024-2030年の世界予測

Intravenous Solutions Market by Type (Peripheral Parenteral Nutrition, Total Parenteral Nutrition), Composition Solution (Carbohydrates, Dextran, Heparin & Trace Element), End-users - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
点滴液市場:タイプ別、組成液別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

点滴液市場規模は2023年に137億6,000万米ドルと推計され、2024年には149億9,000万米ドルに達し、CAGR 9.13%で2030年には253億8,000万米ドルに達すると予測されています。

点滴液は、静脈カテーテルを介して患者の静脈循環に直接投与されるように設計された無菌液体であり、一般に水分補給、電解質不均衡の是正、薬剤の投与、輸血に使用されます。点滴液の組成は、等張液、高張液、低張液など、意図する目的によって大きく異なり、それぞれ特定の治療目的を達成するように調整されています。主成分には生理食塩水、ブドウ糖、電解質、時にはビタミンや薬剤が含まれることが多いです。点滴液の慎重な選択と投与は、急性期および慢性期の医療現場における患者ケアにとって極めて重要です。点滴液の正確な処方と適切な使用を理解することは、効果的な治療結果と患者の安全を確保するための基礎となります。点滴液市場は、慢性疾患の有病率の増加、手術件数の増加、静脈内製剤に関する世界の規制認可の増加によって牽引されています。しかし、点滴液の技術的限界と熟練者の必要性が、点滴液の採用に課題をもたらしています。点滴の効率性と安全性を向上させるための進歩と研究イニシアチブは、点滴液市場の拡大に有利な成長機会を提供しています。

主な市場の統計
基準年[2023] 137億6,000万米ドル
予測年[2024] 149億9,000万米ドル
予測年 [2030] 253億8,000万米ドル
CAGR(%) 9.13%

タイプ栄養・代謝ニーズの高まりにより、全身非経口栄養剤の使用が拡大

末梢非経口栄養(PPN)は末梢静脈から投与され、通常、短期間の栄養補給が必要な患者や栄養要求量がそれほど高くない患者に用いられます。PPNはTPNよりも低濃度の溶液であり、中心静脈カテーテル留置による合併症のリスクを避けなければならない場合にしばしば使用されます。PPN溶液は一般に、タンパク質、炭水化物、ビタミンおよびミネラルを無菌水に溶解したものです。正確な組成は、患者の栄養ニーズ、病状、体重、および体液耐性に基づいて調整されます。必須脂肪酸およびカロリーを供給するために、脂質がしばしば含まれます。全身非経口栄養(TPN)は、中心静脈系に直接投与されるため、高濃度の栄養素を投与できます。この方法は、栄養上の必要性が高い患者、消化管合併症を有する患者、および長期的な栄養支持を必要とする患者に適しています。TPNは消化器系を完全にバイパスし、炭水化物、タンパク質、脂肪、ビタミン、ミネラルなどの必要な栄養素をすべて血流に直接供給することができます。

エンドユーザー広範な患者ニーズに対応する病院・診療所からの需要の高まり

外来手術センターでは、点滴液は手術中の水分補給と安定性を管理するための水分補給に不可欠であり、麻酔薬や鎮静剤を含む薬物投与のための乗り物としても機能し、経口摂取が不可能な場合に必要不可欠な栄養補給を提供します。病院やクリニックのような広範なヘルスケア環境では、外傷やショック症例における緊急時の水分蘇生や、専門診療科における輸血や化学療法への薬物投与など、さまざまな用途で輸液が欠かせません。点滴液は、水分補給と安定性を管理するための輸液に不可欠であり、慢性疾患や高齢の患者をサポートする長期介護の現場でも同様に重要で、水分補給、投薬管理、経口摂取が困難な患者への非経口栄養補給を容易にします。専門クリニックでは、透析における電解質バランス調整、疼痛管理、ホルモン補充などの標的治療など、特定の治療に点滴ソリューションを活用し、正確かつ制御されたケアの提供を実現しています。

地域別インサイト

南北アメリカでは、先進的なヘルスケア施設と業界をリードする企業の存在により、米国を筆頭に点滴液市場が拡大しています。顕著な需要急増は、がん、糖尿病、胃腸障害などの慢性疾患の増加によるものです。南北アメリカは研究開発に力を入れており、革新的な製品のイントロダクションを促進しています。アジア太平洋地域は、可処分所得の増加、ヘルスケアの枠組みの拡大、特に中国やインドなどの経済成長国における健康意識の高まりに後押しされ、市場の急成長が見込まれています。アジア太平洋地域の人口の多さも、医療インフラを改善し、市場に優しい政策を実施する政府の努力に支えられ、点滴液市場拡大の大きな機会を提供しています。EMEA地域は安定した成長を維持しており、欧州は洗練されたヘルスケアシステム、高い患者意識、厳格な規制基準を有しています。中東・アフリカ地域は、主に湾岸協力会議(GCC)諸国と南アフリカにおけるヘルスケア・インフラ投資の活発化とヘルスケア・サービスへの需要の高まりにより、緩やかな成長が予測されます。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは点滴液市場を評価する上で極めて重要です。事業戦略や製品満足度に関する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、点滴液市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.点滴液市場の市場規模および予測は?

2.点滴液市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.点滴液市場の技術動向と規制枠組みは?

4.点滴液市場における主要ベンダーの市場シェアは?

5.点滴液市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 胃腸障害、がん、神経疾患などの慢性疾患および急性疾患の発生率の増加
      • 静脈注射液の規制承認の増加
      • 製品ポートフォリオの強化に向けたメーカー間の戦略的コラボレーションの増加
    • 抑制要因
      • 流体のメンテナンスコストが高い
    • 機会
      • 新興経済諸国からの点滴液の需要増加
      • 患者の利便性を考慮した製品の改善と新たなイノベーション
      • 大腸がん患者に対するビタミンC点滴の実施
    • 課題
      • 点滴液の副作用
  • 市場セグメンテーション分析
    • タイプ:栄養と代謝のニーズの高まりにより、完全静脈栄養の使用が拡大
    • エンドユーザー:幅広い患者のニーズに応えるために病院や診療所からの需要が高まっている
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 点滴液市場:タイプ別

  • 末梢静脈栄養
  • 完全静脈栄養

第7章 点滴液市場作曲ソリューション

  • 炭水化物
  • デキストラン
  • ヘパリンと微量元素
  • 非経口脂質乳剤
  • 単回投与アミノ酸溶液
  • ビタミンとミネラル

第8章 点滴液市場:エンドユーザー別

  • 外来手術センター
  • 病院・クリニック
  • 長期介護施設
  • 専門クリニック

第9章 南北アメリカの点滴液市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の点滴液市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの点滴液市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス、2023
  • 競合シナリオ分析
    • ヒクマ、COMBOGESIC IVの米国での発売を発表
    • サンジヴァニ・パランテラル・リミテッドとHALがIV製剤とIVセットの製造で提携
    • CTMUHBとバクスターが提携し、より安全な点滴輸液投与を実現
  • 戦略分析と提言

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. INTRAVENOUS SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAVENOUS SOLUTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRAVENOUS SOLUTIONS MARKET DYNAMICS
  • FIGURE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 291. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-710B1F0AC675

[194 Pages Report] The Intravenous Solutions Market size was estimated at USD 13.76 billion in 2023 and expected to reach USD 14.99 billion in 2024, at a CAGR 9.13% to reach USD 25.38 billion by 2030.

Intravenous solutions are sterile liquids designed to be administered directly into the venous circulation of a patient via an IV catheter and are commonly used for fluid replacement, correcting electrolyte imbalances, delivering medications, and blood transfusions. The composition of intravenous solutions can vary widely depending on their intended purpose, including isotonic, hypertonic, and hypotonic solutions, each tailored to achieve specific therapeutic objectives. Key constituents often include saline, dextrose, electrolytes, and sometimes vitamins or medications. Careful selection and administration of Intravenous solutions are critical for patient care in acute and chronic medical settings. Understanding the precise formulation and appropriate use of intravenous solutions is foundational to ensuring effective treatment outcomes and patient safety. The intravenous solutions market is driven by an increasing prevalence of chronic diseases, rising incidences of surgeries, and rising regulatory approvals for intravenous formulations globally. However, technical limitations of intravenous solutions and the need for skilled personnel pose a challenge to adopting intravenous solutions. Advancements and research initiatives to improve the efficiency and safety of intravenous fluids are offering lucrative growth opportunities for the Intravenous solutions market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 13.76 billion
Estimated Year [2024] USD 14.99 billion
Forecast Year [2030] USD 25.38 billion
CAGR (%) 9.13%

Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs

Peripheral parenteral nutrition (PPN) is administered through a peripheral vein, typically for patients requiring nutritional support for a short period or when the nutritional requirement is not very high. PPN is a less concentrated solution than TPN and is often used when the risk of complications from central venous catheterization must be avoided. PPN solutions generally contain proteins, carbohydrates, vitamins, and minerals dissolved in sterile water. The precise composition is adjusted based on the nutritional needs of patients, medical conditions, body weight, and fluid tolerance. Lipids are often included to provide essential fatty acids and calories. Total parenteral nutrition (TPN) is delivered directly into the central venous system, allowing for a higher concentration of nutrients to be administered. This method is suitable for patients with significant nutritional needs, gastrointestinal complications, and for those who require long-term nutritional support. TPN can completely bypass the digestive system, directly providing all necessary nutrients such as carbohydrates, proteins, fats, vitamins, and minerals into the bloodstream.

End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs

In ambulatory surgical centers, intravenous solutions are indispensable for fluid replacement to manage hydration and stability during surgeries and also function as vehicles for medication administration, including anesthetics and sedatives, and provide essential nutritional support when oral intake is not feasible. In more extensive healthcare settings, such as hospitals and clinics, IV solutions are vital for various uses, from emergency fluid resuscitation in trauma or shock cases, and medication delivery to blood transfusions and chemotherapy in specialized departments. Intravenous solutions are indispensable for fluid replacement to manage hydration and stability du are equally crucial in long-term care settings for the support of chronically ill or elderly patients, facilitating hydration, medication management, and parenteral nutrition for those unable to consume food orally. Specialty clinics harness IV solutions for specific treatments such as electrolyte balancing in dialysis, pain management, and targeted therapies such as hormone replacements, ensuring precise and controlled care delivery.

Regional Insights

In the Americas, the intravenous solutions market is expanding, with the United States at the forefront due to its advanced healthcare facilities and the presence of leading industry players. A notable demand surge is attributed to the rising cases of chronic diseases such as cancer, diabetes, and gastrointestinal disorders. The Americas benefits from a strong focus on research and development, fostering the introduction of innovative products. The Asia-Pacific region is poised for the fastest market growth, propelled by increasing disposable incomes, expanding healthcare framework, and heightened health awareness, particularly in growing economies such as China and India. The extensive population in the Asia-Pacific region also offers vast opportunities for the intravenous solutions market expansion, supported by government efforts to improve healthcare infrastructure and implement market-friendly policies. The EMEA region maintains steady growth, with Europe having sophisticated healthcare systems, high levels of patient awareness, and stringent regulatory standards. The Middle East and Africa are projected to witness moderate growth, primarily driven by heightened healthcare infrastructure investments and a growing demand for healthcare services in Gulf Cooperation Council (GCC) countries and South Africa.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intravenous Solutions Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intravenous Solutions Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Solutions Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amanta Healthcare Ltd., Anhui Medipharm Co. Ltd, Axa Parenterals Ltd, B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Enzymes Pharmaceuticals, Eurolife Healthcare Pvt. Ltd., Fresenius SE & Co. KGaA, Grifols, S.A., ICU Medical, Inc., JW Life Science Corporation, Lxir Medilabs Pvt. Ltd., Nymak Pharma Ltd., Otsuka Holdings Co., Ltd., Pfizer Inc., Salius Pharma Private Limited, Schwitz Biotech, Sichuan Kelun Pharmaceutical Co., Ltd., Soxa Formulations & Research Pvt. Ltd., Terumo Corporation, Trumac Healthcare, Varni Corporation, and Vifor Pharma Management Ltd..

Market Segmentation & Coverage

This research report categorizes the Intravenous Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Peripheral Parenteral Nutrition
    • Total Parenteral Nutrition
  • Composition Solution
    • Carbohydrates
    • Dextran
    • Heparin & Trace Element
    • Parenteral Lipid Emulsion
    • Single Dose Amino Acid Solution
    • Vitamins & Minerals
  • End-users
    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Long-term Care Facilities
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intravenous Solutions Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intravenous Solutions Market?

3. What are the technology trends and regulatory frameworks in the Intravenous Solutions Market?

4. What is the market share of the leading vendors in the Intravenous Solutions Market?

5. Which modes and strategic moves are suitable for entering the Intravenous Solutions Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
      • 5.1.1.2. Increasing Regulatory Approvals for Intravenous Solution Injections
      • 5.1.1.3. Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Maintenance of Fluids
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in Demand for Intravenous Solutions from Developing Economies
      • 5.1.3.2. Improvements and New Innovations in the Products for Patient Convenience
      • 5.1.3.3. Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects of Intravenous Fluids
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs
    • 5.2.2. End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Intravenous Solutions Market, by Type

  • 6.1. Introduction
  • 6.2. Peripheral Parenteral Nutrition
  • 6.3. Total Parenteral Nutrition

7. Intravenous Solutions Market, by Composition Solution

  • 7.1. Introduction
  • 7.2. Carbohydrates
  • 7.3. Dextran
  • 7.4. Heparin & Trace Element
  • 7.5. Parenteral Lipid Emulsion
  • 7.6. Single Dose Amino Acid Solution
  • 7.7. Vitamins & Minerals

8. Intravenous Solutions Market, by End-users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals & Clinics
  • 8.4. Long-term Care Facilities
  • 8.5. Specialty Clinics

9. Americas Intravenous Solutions Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intravenous Solutions Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intravenous Solutions Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Hikma announces US launch of COMBOGESIC IV
    • 12.3.2. Sanjivani Paranteral Limited and HAL collaborate to manufacture IV formulations and IV Sets
    • 12.3.3. CTMUHB and Baxter partner to implement safer IV fluid administration
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio